Source: PR Newswire

Press Release: twoXAR : twoXAR Pharmaceuticals Rebrands as Aria Pharmaceuticals, Provides Pipeline Update and Announces New Therapeutic Development Strategy

PALO ALTO, Calif., May 4, 2021 /PRNewswire/ -- twoXAR, Inc., a Delaware corporation focused on discovering and bringing first-in-class small molecules to market, today announced that the company will rebrand as Aria Pharmaceuticals. The name reflects the artistry and complexity that...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Andrew A. Radin's photo - Co-Founder & CEO of twoXAR

Co-Founder & CEO

Andrew A. Radin

CEO Approval Rating

81/100

Read more